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We examined the relationship between body fatness, sports participation and breast cancer risk in 1560 premenopausal cases and
1548 controls, from three related population-based case–control studies in the UK. Half of the women with breast cancer were aged
less than 36 years at diagnosis. Women who perceived themselves as plump at age 10 years had a relative risk of 0.83 (95%
confidence interval 0.69–0.99, P¼ 0.03) as compared with those who perceived themselves as thin. Self-reported obesity compared
with leanness at diagnosis was associated with a relative risk of 0.78 (95% confidence interval 0.56–1.06, P¼ 0.11). Women who
reported having been plump at age 10 years and overweight or obese at diagnosis had a relative risk of 0.75 (95% confidence interval
0.56–1.01, P¼ 0.06) as compared with those who reported being thin at age 10 years and at diagnosis. Findings for three related
measures of body fatness suggested that obesity is associated with a reduced risk of premenopausal breast cancer. There was no
association between sports participation and breast cancer risk in these premenopausal women. The relative risk for spending an
average of more than 1 h per week in sports compared with less from ages 12 to 30 years was 1.00 (95% CI 0.86–1.16, P¼ 0.98).
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Obesity in adulthood has been related to a decreased risk of
premenopausal breast cancer, but data on the relationship with
body fatness in childhood and adolescence are limited (IARC,
2002; Okasha et al, 2003). Although an expert group convened by
the International Agency for Research on Cancer concluded that
there was sufficient evidence that physical activity reduced the risk
of premenopausal breast cancer (IARC, 2002), results from more
recent studies have been contradictory (Adams-Campbell et al,
2001; Gilliland et al, 2001; Matthews et al, 2001; Colditz et al, 2003;
Dorn et al, 2003; Hirose et al, 2003; John et al, 2003; Steindorf et al,
2003; Yang et al, 2003; Margolis et al, 2005).
We report here on the relationship between premenopausal
breast cancer, body fatness at age 10 years and in adulthood, and
sports participation during puberty, late adolescence and early
adulthood from three related UK case–control studies.
MATERIAL AND METHODS
Study population
This investigation includes data from three related UK population-
based case– control studies of breast cancer of a similar design:
cases were diagnosed between 1 January 1982 and 31 December
1985, below age 36 years in the first (UK National Case-Control
Study Group, 1989); between 1 January 1988 and 30 June 1989
at ages 36–45 years in the second; and between 1 July 1990 and
30 June 1991 at ages 46–54 years in the third (unpublished data).
Residents of many parts of England but not East Anglia in Greater
Glasgow, Lothian, Borders and Fife were included in the study
of women younger than 36 years, while only Thames, Oxford and
Yorkshire, and only Oxford and Yorkshire Regions constituted
catchments areas for the other two studies. The studies were
restricted to white women with no previous malignancy (except
nonmelanoma skin cancer), severe mental handicap or illness.
Cases were women with an incident invasive breast cancer,
identified chiefly through the Regional Cancer Registries, and
supplemented by hospital discharge records from Hospital Activity
Analysis registers and patient lists kept at major treatment centres.
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Permission from hospital consultants and general practitioners
was obtained before names were disclosed by the Cancer Registry
and before women were contacted. Breast cancer was confirmed
when case notes were reviewed in 97% of cases. Out of 1049, 838
and 635 eligible cases in the three studies of women less than 36,
36–45 and 46–54 years of age, 755 (72%), 644 (77%) and 535
(84%), respectively, were interviewed. Reasons for nonparticipa-
tion included consultants’ or general practitioners’ refusal (7, 6
and 2%), woman’s own refusal (3, 3 and 2%), death (16, 11 and
9%) and relocation from the study area (3, 3 and 2%, respectively).
For each case, one age-matched control was randomly selected
from the list of the case’s general practitioner. If a chosen control
could not be interviewed, a further age-matched control was
selected at random. Of the 755, 644 and 535 first eligible controls in
the studies of women less than 36, 36 –45 and 46–54 years of age,
675 (89%), 588 (91%) and 491 (92%), respectively, were
interviewed. Reasons for first controls’ nonparticipation included
refusal by the general practitioners (2, 3 and 2% respectively) or
the woman herself (8, 6 and 6% respectively).
Data collection
Participants were interviewed in their homes using a standardised
structured questionnaire, each case–control pair by the same
trained interviewer, on average 2 years after diagnosis in each
study. Women were asked to state whether they had been thin,
average or plump at age 10 years, their weight at age 20 years and
their weight and height at diagnosis (or equivalent). Participants
were further asked about the number of hours spent per week in
compulsory school sports at ages 12, 14, 16 and 18 years as well as
the number of hours per week in all other sports at ages 12, 14, 16,
18, 20, 25, 30, 35, 40, 45 and 50 years, as appropriate. They were
also asked about their menstrual history and other risk factors
for breast cancer. The information requested, the structure of the
questionnaire and phrasing of the questions was similar in the
three studies.
Classification of body fatness and participation in sports
Perceived body fatness at age 10 years was classified according to
the women’s responses as thin, average or plump. Body mass index
(BMI) at age 20 years and at around the time of diagnosis was
calculated as weight (kg) divided by the square of height (m);
women were categorised as being thin, average or overweight if
they had a BMI ofo20.0, 20.0–22.5 or 422.5 kg m2, respectively,
at age 20 or o22.5, 22.5–25.0 or 425.0 kg m2, respectively, at
diagnosis. The subjects were also crossclassified by (a) their body
fatness at age 10 years and their BMI at age 20 years and (b) their
body fatness at age 10 years and their BMI at diagnosis, according
to the following nine categories: thin/thin; thin/average; thin/
overweight; average/thin; average/average; average/overweight;
plump/thin; plump/average and plump/overweight.
We used the self-reported information on sports participation
to create indices of the average number of hours per week of
participation in compulsory school and other sports at around
puberty (ages 12– 14 years), late adolescence (ages 16–18 years),
early adulthood (ages 20–30 years), at around diagnosis (the most
recent 10-year interval) and during all young ages (ages 12– 30
years).
Statistical analyses
Women were defined as postmenopausal if they reported having
had natural menopause (n¼ 306), bilateral oophorectomy (n¼ 32)
or hysterectomy and were aged 48 years or older at diagnosis
(n¼ 154). All analyses were restricted to premenopausal women,
with users of hormone replacement therapy in this group being
further excluded (n¼ 270). Thus, the final study group comprised
1560 cases and 1548 controls.
Conditional logistic regression was used for all analyses with
stratification by age at diagnosis (single year) and region of
recruitment. Odds ratios as estimates of relative risks (RRs) and
95% confidence intervals (CIs) are reported. Where more than two
groups were compared, variances were estimated by treating the
relative risks as floating absolute risks (FARs). This approach
yields floated standard errors and floated confidence intervals
(Easton et al, 1991; Plummer, 2004). Presentation of the results in
this way enables valid comparisons between any two exposure
groups, even if neither is the baseline.
All estimates were routinely adjusted for parity and age at first
birth (nulliparous, parous and age at first birth o25, parous and
age at first birth X25), height (o162, X162 cm), use of oral
contraceptives (never user, user within the last 5 years, user more
than 5 years ago), alcohol consumption (non-drinkers, drinkers),
family history of breast cancer (no history, mother and/or sister
with breast cancer) and socioeconomic status (nonmanual/
professional, manual/unemployed/housewife). In addition to these
standard factors, we further adjusted results for perceived body
fatness at age 10 years, the number of hours of participation in
sports at young ages and at diagnosis (0–1, 2–3, 4þ hours
week1), age at menarche (o13, 13þ years), time from menarche
to onset of regular cycles (o1 year, 1þ years) and history of
irregular menstrual cycles (no history, positive history). Corres-
pondingly, we also adjusted results of early participation in sports
for perceived body fatness at age 10 years (thin, average, plump),
BMI at age 20 (o20, 20–22.5, 22.5þ ) years, BMI at diagnosis
(o22.5, 22.5–25.0, 25.0þ ) years and menstrual characteristics as
above.
Lastly, we explored whether the impact of body fatness at age 10
years and sports participation at young ages varied with levels of
one another and with other factors including the standard set of
adjustment variables and menstrual characteristics. Analyses were
conducted using the data from all studies combined, since
sensitivity analyses, estimating each model separately within each
study, were not indicative of the associations being materially
different between studies.
All analyses were performed using Stata version 8.1 (Stata
Corporation, College Station, Texas, USA). All statistical signifi-
cance levels (P-values) quoted are two sided.
RESULTS
Characteristics of cases and controls are given in Table 1. Almost
half were less than 36 years, about half were from nonmanual or
professional social classes, most were parous, and most had used
oral contraceptives.
Among the controls, 40% perceived themselves as thin and 22%
as plump at age 10 years. There was a statistically significant trend
of a decreasing risk of breast cancer with increasing self-reported
body fatness at age 10 years (P¼ 0.03) (Figure 1). Women who
reported having been plump at age 10 years had a borderline
statistically significantly lower risk than women who reported
having been of thin or average body build (RR¼ 0.83, 95% CI
0.69– 0.99). These associations were not affected by adjustment for
BMI at age 20 years or for BMI at diagnosis (Figure 1).
Neither BMI at age 20 years nor BMI at diagnosis, within the
narrow BMI range under study, was significantly related to risk
among premenopausal women (Figure 1). Among controls, the
mean BMI at age 20 years and at pseudodiagnosis were 21.5 and
23.3 kg m2, respectively. Only 0.2 and 6.5% were obese (i.e. had a
BMI X30 kg m2) at age 20 years and at diagnosis, respectively.
The RR in the small subgroup of women who were obese at
diagnosis was 0.78 (95% CI 0.56–1.06), as compared with those
who had a BMI of less than 22.5 kg m2. As compared with women
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who were under- or normal weight, those who reported to be
overweight (i.e. had a BMI X25 kg m2) at age 20 years or at
diagnosis were not at a significantly altered risk of breast cancer
(RR¼ 0.93 (95% CI 0.72– 1.19) and 0.98 (95% CI 0.80– 1.21),
respectively).
Table 2 shows results for women crossclassified according to
their perceived body fatness at age 10 years and their BMI at
diagnosis. The lowest RR was among women who reported having
been plump at age 10 years and who were overweight or obese at
diagnosis (RR¼ 0.75, 95% CI 0.54–1.01). No significant interac-
tions were found between the effects of perceived body fatness
at age 10 years and BMI at diagnosis (Table 2), nor between the
effects of perceived body fatness at age 10 years and BMI at age 20
years (data not shown).
The average numbers of hours that controls reported
engaging in sports, at ages 12–14, 16– 18, 20 –30 years, at all
Table 1 Descriptive characteristics of cases and controls
Cases (%) Controls (%)
Characteristic n¼ 1560 n¼1548
Age at diagnosis/pseudodiagnosis (years)
Study 1, women aged o36 years 751 (48) 748 (48)
Study 2, women aged 36–45 years 596 (38) 598 (39)
Study 3, women aged 46–55 years 213 (14) 202 (13)
Socioeconomic status
Nonmanual/professional 809 (52) 804 (52)
Manual/unemployed/housewife 751 (48) 744 (48)
Use of oral contraceptives
Never 250 (16) 259 (17)
Last use o5 years ago 663 (41) 567 (37)
Last use X5 years ago 647 (43) 722 (47)
Alchohol consumption
Non-drinkers 516 (33) 516 (34)
Drinkers 1047 (67) 1032 (66)
History of breast cancer in first-degree
relative
No 1357 (89) 1425 (94)
Yes 165 (11) 86 (6)
Mean height (cm) 163.3 162.3
Mean age at menarche (years) 12.6 12.7
Mean time from menarche to onset of
regular menstrual cycles (months)
11 11
Parity
Nulliparous 270 (17) 230 (15)
Parous 1290 (83) 1318 (85)
Mean age at first birth, years (among
parous)
24 23.8
History of irregular menstrual cycles
Yes 306 (20) 287 (19)
No 1248 (80) 1256 (81)
Perceived body fatness at age 10 years
   Thin 636/591 1.05 1.05 (0.93−1.20)
   Average 636/620 1.00 1.00 (0.90−1.11)
   Plump 286/335 0.82 0.82 (0.69−0.98)
  2 for trend = 4.49; P = 0.03
Body mass index at age 20 years (kg m−2)
   <20 524/508 1.00 1.00 (0.86−1.17)
   2022.5 594/600 0.97 0.99 (0.90−1.09)
  22.5 426/430 0.98 1.09 (0.92−1.30)
  2 for trend = 0.46; P = 0.50
Body mass index at diagnosis/pseudodiagnosis (kg m−2)
   <22.5 703/691 1.00 1.00 (0.87−1.15)
   22.525 516/508 1.02 1.03 (0.92−1.14)
  25 338/346 0.96 0.96 (0.80−1.14)
  2 for trend = 0.08; P = 0.78
Measure of body fatness
Cases/
controls
0.5 1.0 2.0
RR1 RR2 (95% FCI) RR2 and 95% FCI
1
 Stratified by age and recruitment region, adjusted for parity and age at first birth, height, use of oral
  contraceptives and alcohol consumption.
2
 As 1 but further adjusted for perceived body fatness at age 10 years, body mass index at age 20 years
  and at diagnosis/pseudodiagnosis, as applicable.
Figure 1 Relative risk of premenopausal breast cancer in relation to perceived body fatness at age 10 years, body mass index at age 20 years and at
diagnosis/pseudodiagnosis. Black squares indicate relative risks (RRs), area of which is proportional to the amount of information contributed (i.e., to the
inverse of the variance of the logarithm of the RRs). Lines indicate 95% floated confidence intervals (FCIs; see Material and Methods).
Table 2 Relative risk of premenopausal breast cancer in relation to
change in body fatness between age 10 years and diagnosis/pseudo-
diagnosis
Body fatness at age 10
yearsa and at diagnosis/
pseudodiagnosisb Cases/controls RRc 95% FCId
Thin/thin 377/341 1.00 0.86–1.16
Thin/average 162/166 0.89 0.72–1.12
Thin/overweight 97/84 1.04 0.77–1.40
Average/thin 254/272 0.84 0.71–1.00
Average/average 249/219 1.05 0.88–1.27
Average/overweight 133/130 0.92 0.72–1.18
Plump/thin 73/79 0.85 0.61–1.17
Plump/average 105/124 0.79 0.61–1.03
Plump/overweight 108/132 0.75 0.58–0.97
aPerceived body fatness at age 10 years. bBody fatness at diagnosis in cases and at an
equivalent time in controls, based on body mass index (BMI) (thin¼ BMIo20 kg m2,
average¼ BMI 20–25 kg m2 and overweight¼ BMIX25 kg m2). cRelative risk,
compared with thin/thin women, stratified by age and recruitment region, adjusted
for parity, age at first birth, height, use of oral contraceptives and alcohol
consumption. dFloated confidence intervals (see Material and Methods).
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young ages (12–30 years) and at pseudodiagnosis were 4.7, 2.9, 1.3,
2.8 and 1.3 per week, respectively. Sports participation at these
ages was not related to breast cancer risk (Figure 2). The RR for
participating in sports for more than an hour each week from
ages 12 to 30 years compared with less often was 1.00 (95% CI
0.86– 1.16).
At ages 12−14 years
   0−1 h week−1 150/158 1.00 (0.79−1.26)
   2−3 h week−1 589/573 1.04 (0.93−1.17)
   4 h week−1 819/813 1.03 (0.93 −1.14)
   2 for trend = 0.004; P = 0.95
Cases /
controls RR1 (95% FCI) RR1 and 95% FCISports participation
At ages 16−18 years
   0−1 h week−1 653/629 1.00 (0.89−1.12)
   2−3 h week−1 425/417 0.95 (0.83−1.09)
   4 h week−1 479/499 0.89 (0.79−1.02)
   2 for trend = 1.64; P = 0.20
At ages 20−30 years
   0−1 h week−1 1139/1124 1.00 (0.91−1.10)
   2−3 h week−1    247/261 0.90 (0.76−1.08)
   4 h week−1   170/159 1.01 (0.81−1.26)
   2 for trend = 0.12; P = 0.73
At all young ages (12−30 years)
   0−1 h week−1 564/566 1.00 (0.88−1.13)
   2−3 h week−1 589/587 0.99 (0.89−1.11)
   4 h week−1 405/393 1.01 (0.88−1.16)
   2 for trend = 0.006; P = 0.94
At around diagnosis/pseudodiagnosis
   0−1 h week−1 1107/1135 1.00 (0.91−1.10)
   2−3 h week−1    279/246 0.84 (0.71−1.00) 
    4 h week−1    158/175 1.06 (0.86−1.32)
   2 for trend = 0.05; P = 0.82
0.5 1.0 2.0
1
 Stratified by age and recruitment region, adjusted for parity and age at first birth, height, use of oral
  contraceptives and alcohol consumption.
Figure 2 Relative risk of premenopausal breast cancer in relation to participation in sports at different ages. Black squares indicate relative risks (RRs), area
of which is proportional to the amount of information contributed (i.e., to the inverse of the variance of the logarithm of the RRs). Lines indicate 95% floated
confidence intervals (FCIs; see Material and Methods).
Table 3 Relative risk of premenopausal breast cancer in relation to (A) perceived body fatness at age 10 years and (B) participation in sports at young
ages, with and without adjustment for body fatness, participation in sports at different ages and menstrual characteristics
Thin Average Plump
(A) Model/perceived body fatness at age 10 years RRa 95% FCIb RRa 95% FCIb RRa 95% FCIb
Multivariate-adjustedc 1.05 0.94–1.17 1.00 0.89–1.12 0.85 0.72–0.99
Multivariatec+participation in sports at all young ages 1.05 0.93–1.17 1.00 0.89–1.12 0.84 0.72–0.99
Multivariatec+participation in sports at diagnosis/pseudodiagnosis 1.04 0.93–1.17 1.00 0.89–1.12 0.84 0.72–0.99
Multivariatec+menstrual characteristicsd 1.06 0.95–1.20 1.00 0.89–1.12 0.84 0.72–0.99
0–1 h week1 2–3 h week1 4+ h week1
(B) Model/average duration of sports participation at ages 12–30 years RRe 95% FCIb RRe 95% FCIb RRe 95% FCIb
Multivariate-adjustedc 1.00 0.90–1.13 0.99 0.89–1.11 1.01 0.88–1.16
Multivariatec+body fatness at age 10 1.00 0.88–1.13 0.99 0.88–1.11 1.00 0.87–1.16
Multivariatec+body mass index (BMI) at age 20 years 1.00 0.88–1.13 0.98 0.87–1.10 1.00 0.86–1.14
Multivariatec+BMI at diagnosis/pseudodiagnosis 1.00 0.88–1.13 0.99 0.88–1.11 1.01 0.87–1.16
Multivariatec+menstrual characteristicsd 1.00 0.88–1.13 0.98 0.88–1.10 1.00 0.87–1.15
aRelative risk, compared with women who reported to be of average body fatness at age 10 years. bFloated confidence intervals (see Material and Methods). cStratified by age
and recruitment region, adjusted for parity, age at first birth, height, use of oral contraceptives and alcohol consumption. dAdditional adjustments for age at menarche, time from
menarche to onset of regular cycles and irregular menstrual cycles at ages 20–30 years. eRelative risk, compared with women who reported to participate 1 h or less per week in
sports at young ages.
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Study/age at diagnosis/pseudodiagnosis
   Women aged <36 years 750/748 0.82 (0.64−1.05)
   Women aged 36−45 years 596/597 0.78 (0.58−1.04)
   Women aged 46−54 years 213/200 0.91 (0.54−1.55)
   2 for heterogeneity = 0.29; P = 0.87
Body mass index at diagnosis/pseudodiagnosis (kg m−2)
   < 22.5 805/779 0.77 (0.56−1.05)
  22.5 729/735 0.83 (0.66−1.05)
  2 for heterogeneity = 0.13; P = 0.72
Sports participation at all young ages
  0−1 h week−1 552/544 0.80 (0.59−1.07)
  2 h week−1 987/968 0.83 (0.66−1.04)
  2 for heterogeneity = 0.00; P = 1.00
Age at menarche (years)
   < 13 711/667 0.81 (0.64−1.04)
  13 819/834 0.77 (0.59−1.01)
  2 for heterogeneity = 1.18; P = 0.28
Time from menarche to onset of regular menstrual cycles
   < 1 year 1186/1157 0.76 (0.62−0.94)
  1 year   306/325 0.85 (0.56−1.28)
  2 for heterogeneity = 1.12; P = 0.29
Regularity of menstrual cycles at ages 20 −30 years
   Regular 1241/1245 0.81 (0.66−0.98)
   Irregular   265/253 0.87 (0.56−1.35)
  2 for heterogeneity = 0.00; P = 1.00
Parity and age at first birth
   Nulliparous 239/202 0.74 (0.46−1.21)
   Age at first birth < 25 years 718/778 0.74 (0.58−0.96)
   Age at first birth25 years 434/511 0.99 (0.72−1.35)
  2 for heterogeneity = 1.75; P = 0.42
Height (cm)
   < 163 853/867 0.79 (0.63−1 .00)
  163 679/649 0.87 (0.65−1.1 6)
  2 for heterogeneity = 0.00; P = 1.00
Oral contraceptive use
   Never use 226/221 0.65 (0.39−1.06)
   Time since last use < 5 years 628/577 0.79 (0.59−1.05)
   Time since last use  5 years 655/706 1.05 (0.80−1.37)
  2 for heterogeneity = 2.70; P = 0.26
Alcohol consumption
   Non-drinkers    498/485 0.70 (0.51−0.96)
   Drinkers 1039/1026 0.86 (0.69−1.08)
  2 for heterogeneity = 2.02; P = 0.16
History of breast cancer in first degree relative
   Yes    103/68 0.78 (0.33−1.87)
   No 1353/1421 0.81 (0.67−0.98)
  2 for heterogeneity = 0.00; P = 1.00
Socioeconomic status
   High 789/789 0.85 (0.66−1.09)
   Low 739/736 0.80 (0.62−1.04)
  2 for heterogeneity = 0.00; P = 1.00
All women 1558/1546 0.83 (0.69−0.99)
Cases/
controls RR1 (95% CI) RR1 and 95% CICharacteristic
0.5 1.0 2.01
 Stratified by age and recruitment region.
Figure 3 Relative risk for premenopausal breast cancer in women who perceived themselves as having been plump compared to thin or average at age
10 years, by different characteristics. Black squares indicate relative risks (RRs), area of which is proportional to the amount of information contributed (i.e., to
the inverse of the variance of the logarithm of the RRs). Lines indicate 95% confidence intervals (CIs).
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Study/age at diagnosis/pseudodiagnosis
   Women aged <36 years 750/748 1.10 (0.88−1.36)
   Women aged 36−45 years 596/597 0.97 (0.76−1.22)
   Women aged 46−54 years 213/200 0.91 (0.61−1.37)
   2 for heterogeneity = 0.95; P = 0.62
Perceived body fatness at age 10 years
   Thin/average 1268/1207 0.98 (0.83−1.16)
   Plump   259/303 1.14 (0.79−1.64)
   2 for heterogeneity = 0.50; P = 0.48
Body mass index at age 20 years (kg m−2)
   < 20   500/495 0.92 (0.70 −1.20)
  20 1012/1025 1.06 (0.88−1.27)
   2 for heterogeneity = 0.74; P = 0.39 
Body mass index at diagnosis/pseudodiagnosis (kg m−2)
   < 22.5 805/779 1.02 (0.82−1.26)
  22.5 729/738 0.95 (0.76−1.17)
   2 for heterogeneity = 0.27; P = 0.60
Age at menarche ( years)
   < 13 711/667 1.04 (0.83−1.30)
  13 819/834 1.00 (0.81−1.22)
   2 for heterogeneity = 0.08; P = 0.78
Time from menarche to onset of regular menstrual cycles
   < 1 year 1186/1157 0.98 (0.83−1.17)
  1 year   306/325 1.04 (0.74−1.47)
   2 for heterogeneity = 0.09; P = 0.76
Regularity of menstrual cycles at ages 20 −30 years
   Regular 1241/1245 1.04 (0.88−1.22)
   Irregular 265/253 0.97 (0.66−1.42)
   2 for heterogeneity = 0.01; P = 0.92
Parity and age at first birth
   Nulliparous 239/202 1.38 (0.87−2.17)
   Age at first birth <25 years 718/778 1.03 (0.83−1.27)
   Age at first birth25 years 534/511 0.88 (0.67−1.15)
   2 for heterogeneity = 2.56; P = 0.28
Height (cm)
   < 163 853/867 0.99 (0.81−1.21)
  163 679/649 1.04 (0.82−1.31)
   2 for heterogeneity = 0.07; P = 0.79
Oral contraceptive use
   Never use 226/221 1.19 (0.79−1.80)
   Time since last use <5 years 628/557 1.04 (0.81−1.34)
   Time since last use5 years 655/706 0.93 (0.75−1.16)
   2 for heterogeneity = 1.12; P = 0.57
Alcohol consumption
   Non-drinkers   498/485 1.19 (0.91−1.54)
   Drinkers 1039/1026 0.96 (0.79−1.15)
   2 for heterogeneity = 1.73; P = 0.19
History of breast cancer in first-degree relative
   Yes   103/68  0.69 (0.34−1.41)
   No 1353/1421 1.04 (0.89−1.22)
   2 for heterogeneity = 1.24; P = 0.27
Socioeconomic status
   High 789/789 0.93 (0.75−1.16)
   Low 739/736 1.05 (0.85−1.30)
   2 for heterogeneity = 0.61; P = 0.43
All women 1558/1546 1.00 (0.86−1.16)
1
 Stratified by age and recruitment region.
0.5 1.0 2.0
Cases/
controls RR1 (95% CI) RR1 and 95% CICharacteristic
 
Figure 4 Relative risk for premenopausal breast cancer in women who reported participating in sports more than one compared to 1 h or less per week
at ages 12–30 years, by different characteristics. Black squares indicate relative risks (RRs), area of which is proportional to the amount of information
contributed (i.e., to the inverse of the variance of the logarithm of the RRs). Lines indicate 95% confidence intervals (CIs).
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Further adjustment of perceived body fatness at age 10 for
participation in sport or age at menarche and other menstrual
factors, and participation in sport for body fatness at different ages
or menstrual factors, did not alter the risk estimates (Table 3).
Similarly, adjustments for age at menarche, other menstrual
factors or participation in sports did not affect the associations
between the risk of breast cancer, BMI at age 20 years and BMI at
diagnosis (data not shown).
The observed relationships between breast cancer, perceived
body fatness at age 10 years and participation in sports at ages
12–30 years did not vary significantly with levels of other
characteristics (Figures 3 and 4). In some subgroups, however,
the validity of the results is limited by the small number of
observations.
DISCUSSION
In this large, population-based case–control study of premeno-
pausal women, three related measures of body fatness suggested
that obesity in premenopausal women is associated with a reduced
risk of breast cancer. Women who perceived themselves as plump
at age 10 years had an RR of 0.83 (95% CI 0.69–0.99, P¼ 0.03)
compared with those who perceived themselves as thin. Self-
reported obesity compared with leanness at diagnosis was
associated with an RR of 0.78 (95% CI 0.56– 1.06, P¼ 0.11), and
women who reported having been both plump at age 10 years and
overweight at diagnosis had an RR of 0.75 (95% CI 0.56–1.01,
P¼ 0.06) as compared with those thin at age 10 years and at
diagnosis. We did not find a relationship between any level of BMI
at age 20 years and risk, but few women reported having been
obese or even overweight at that age. The modest evidence of an
inverse association between body fatness at age 10 years and risk
of breast cancer among premenopausal women in our data is
consistent with other reports (Berkey et al, 1999; Swerdlow et al,
2002; Okasha et al, 2003; Ahlgren et al, 2004; De Stavola et al, 2004;
Weiderpass et al, 2004), as is the suggested protective effect of
obesity at diagnosis (IARC, 2002). Although body fatness in
childhood and early adulthood has been proposed to influence
breast carcinogenesis via anovulatory-related progesterone defi-
ciency, decelerated adolescent growth and oestrogen-induced
breast epithelial differentiation (Berkey et al, 1999; Cabanes et al,
2004; Magnusson and Roddam, 2005), there is no direct evidence
to support these mechanisms.
We did not observe any association between sports participation
at puberty, late adolescence, early adulthood or at diagnosis and
breast cancer risk in premenopausal women. The RR of breast
cancer associated with an average of more than an hour each week
of sports participation from ages 12 to 30 years, as compared with
less often, was 1.00 (95% CI 0.86–1.16, P¼ 0.98). Recent reviews
concluded that physical activity both at young ages and in
adulthood reduced the risk of breast cancer; IARC (2002) and
Lagerros et al (2004). However, subsequent findings concerning
premenopausal breast cancer are inconsistent, both for physical
activity at young ages (Dorn et al, 2003; Steindorf et al, 2003; Yang
et al, 2003; Margolis et al, 2005) and around diagnosis (Adams-
Campbell et al, 2001; Gilliland et al, 2001; Matthews et al, 2001;
Colditz et al, 2003; Dorn et al, 2003; Hirose et al, 2003; John et al,
2003; Steindorf et al, 2003; Yang et al, 2003; Margolis et al, 2005).
Without evidence from a formal meta-analysis using individual
data from all relevant studies, it is difficult to interpret the
available results.
This is the largest study of premenopausal breast cancer on
body fatness and sports participation at young ages with an over
80% power to detect an RR of 0.77 or less for at least 4 h week1 of
sports participation at young ages. It is population based, and had
high participation rates among both cases and controls. It included
detailed information about body fatness at different ages, and
life-course physical activity including its duration, as well as about
potential confounding factors. Nevertheless, differential and
nondifferential misclassification may limit the validity of findings
based on retrospective assessment of exposures. In addition, we
lacked information on types of physical activity other than sports
(for example, occupational physical activity, housework, gardening
and transportation). However, sports participation could, however,
be assumed to account for the major proportion of physical
activity at young ages.
In summary, this large study provides evidence of an inverse
association between body fatness, but not physical activity,
at young ages and the risk of breast cancer in premenopausal
women.
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